reduce basal insulin dose when starting glp-1 receptor agonist Adding a was not associated with a lower likelihood of discontinuing existing therapy among veterans with type 2 diabetes compared with other glucose-lowering agents, a target emulation GLP-1 Receptor Agonists for the

We also discuss combination therapies and strategies to mitigate muscle mass loss during treatment and calls for targeted research, improved clinical education, and policy reforms to optimize the translational potential of GLP-1R agonists in both individualized care and population health

Obesity is the fifth leading risk factor for global deaths with numbers continuing to increase worldwide

/PRNewswire/ -- Ro, the leading direct-to-patient healthcare company, today announced eligible patients can now access Foundayo (orforglipron) Eli Lilly...

Improved blood sugar regulation and metabolic health

Data on bone health in the context of calorie restriction and bariatric surgery were also summarized

Other oral compounds like CT-996 / RG 6652 showed a clinically meaningful weight reduction of 6-7% in four weeks among participants without T2D, and GSBR-1290 has demonstrated favourable safety, tolerability and efficacy results